Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with parkinson's disease

Identifieur interne : 005D57 ( Main/Exploration ); précédent : 005D56; suivant : 005D58

Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with parkinson's disease

Auteurs : Robert A. Hauser [États-Unis] ; Olanow [États-Unis]

Source :

RBID : ISTEX:E358AD7CB53375B5223EB082DFBF3E90AB24D25F

Descripteurs français

English descriptors

Abstract

Dyskinesia is a common adverse effect complicating chronic dopaminergic therapy for Parkinson's disease. Movements are frequently choreic in nature and have been ascribed to overstimulation of “supersensitive” striatal postsynaptic dopamine receptors. Anticholinergic medications, despite some clinical efficacy in Parkinson's disease, have rarely been reported to cause dyskinesia. We report a patient with Parkinson's disease who developed orobuccal dyskinesia while being treated with trihexyphenidyl (Artane). Dyskinesia was observed following the introduction of trihexyphenidyl, resolved with its discontinuation, and reappeared with its reinstitution. Carbidopa‐levodopa (Sinemet) alone did not cause dyskinesia but augmented dyskinesia associated with trihexyphenidyl.

Url:
DOI: 10.1002/mds.870080417


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with parkinson's disease</title>
<author>
<name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A." last="Hauser">Robert A. Hauser</name>
</author>
<author>
<name sortKey="Olanow" sort="Olanow" uniqKey="Olanow" last="Olanow">Olanow</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:E358AD7CB53375B5223EB082DFBF3E90AB24D25F</idno>
<date when="1993" year="1993">1993</date>
<idno type="doi">10.1002/mds.870080417</idno>
<idno type="url">https://api.istex.fr/document/E358AD7CB53375B5223EB082DFBF3E90AB24D25F/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003859</idno>
<idno type="wicri:Area/Istex/Curation">003859</idno>
<idno type="wicri:Area/Istex/Checkpoint">004024</idno>
<idno type="wicri:doubleKey">0885-3185:1993:Hauser R:orobuccal:dyskinesia:associated</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:8232363</idno>
<idno type="wicri:Area/PubMed/Corpus">004B78</idno>
<idno type="wicri:Area/PubMed/Curation">004B78</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004C28</idno>
<idno type="wicri:Area/Ncbi/Merge">004941</idno>
<idno type="wicri:Area/Ncbi/Curation">004941</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004941</idno>
<idno type="wicri:doubleKey">0885-3185:1993:Hauser R:orobuccal:dyskinesia:associated</idno>
<idno type="wicri:Area/Main/Merge">008F96</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:94-0143150</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003665</idno>
<idno type="wicri:Area/PascalFrancis/Curation">003159</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">003655</idno>
<idno type="wicri:doubleKey">0885-3185:1993:Hauser R:orobuccal:dyskinesia:associated</idno>
<idno type="wicri:Area/Main/Merge">009075</idno>
<idno type="wicri:Area/Main/Curation">005D57</idno>
<idno type="wicri:Area/Main/Exploration">005D57</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with parkinson's disease</title>
<author>
<name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A." last="Hauser">Robert A. Hauser</name>
<affiliation wicri:level="4">
<country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea>Department of Neurology, University of South Florida, Tampa, Florida</wicri:regionArea>
<placeName>
<region type="state">Floride</region>
<settlement type="city">Tampa</settlement>
</placeName>
<orgName type="university">Université de Floride du Sud</orgName>
</affiliation>
</author>
<author>
<name sortKey="Olanow" sort="Olanow" uniqKey="Olanow" last="Olanow">Olanow</name>
<affiliation wicri:level="4">
<country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea>Department of Psychiatry, Pharmacology and Experimental Therapeutics, University of South Florida, Tampa, Florida</wicri:regionArea>
<placeName>
<region type="state">Floride</region>
<settlement type="city">Tampa</settlement>
</placeName>
<orgName type="university">Université de Floride du Sud</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1993">1993</date>
<biblScope unit="vol">8</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="512">512</biblScope>
<biblScope unit="page" to="514">514</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">E358AD7CB53375B5223EB082DFBF3E90AB24D25F</idno>
<idno type="DOI">10.1002/mds.870080417</idno>
<idno type="ArticleID">MDS870080417</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Acetylcholine</term>
<term>Antagonist</term>
<term>Anticholinergic</term>
<term>Antiparkinson agent</term>
<term>Buccofacial dyskinesia</term>
<term>Case study</term>
<term>Dyskinesia</term>
<term>Dyskinesia, Drug-Induced</term>
<term>Human</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parasympatholytics (adverse effects)</term>
<term>Parasympatholytics (therapeutic use)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Toxicity</term>
<term>Trihexyphenidyl</term>
<term>Trihexyphenidyl (adverse effects)</term>
<term>Trihexyphenidyl (therapeutic use)</term>
<term>Videotape Recording</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Parasympatholytics</term>
<term>Trihexyphenidyl</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Parasympatholytics</term>
<term>Trihexyphenidyl</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Dyskinesia, Drug-Induced</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Videotape Recording</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Acétylcholine</term>
<term>Antagoniste</term>
<term>Antiparkinsonien</term>
<term>Dyskinésie buccofaciale</term>
<term>Etude cas</term>
<term>Homme</term>
<term>Parkinson maladie</term>
<term>Toxicité</term>
<term>Trihexyphénidyle</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Homme</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Dyskinesia is a common adverse effect complicating chronic dopaminergic therapy for Parkinson's disease. Movements are frequently choreic in nature and have been ascribed to overstimulation of “supersensitive” striatal postsynaptic dopamine receptors. Anticholinergic medications, despite some clinical efficacy in Parkinson's disease, have rarely been reported to cause dyskinesia. We report a patient with Parkinson's disease who developed orobuccal dyskinesia while being treated with trihexyphenidyl (Artane). Dyskinesia was observed following the introduction of trihexyphenidyl, resolved with its discontinuation, and reappeared with its reinstitution. Carbidopa‐levodopa (Sinemet) alone did not cause dyskinesia but augmented dyskinesia associated with trihexyphenidyl.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Floride</li>
</region>
<settlement>
<li>Tampa</li>
</settlement>
<orgName>
<li>Université de Floride du Sud</li>
</orgName>
</list>
<tree>
<country name="États-Unis">
<region name="Floride">
<name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A." last="Hauser">Robert A. Hauser</name>
</region>
<name sortKey="Olanow" sort="Olanow" uniqKey="Olanow" last="Olanow">Olanow</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005D57 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005D57 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:E358AD7CB53375B5223EB082DFBF3E90AB24D25F
   |texte=   Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with parkinson's disease
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024